Silo Pharma Stock Today
| SILO Stock | USD 1.20 0.03 2.56% |
Performance2 of 100
| Odds Of DistressOver 85
|
Silo Pharma is selling at 1.20 as of the 31st of August 2024; that is 2.56 percent increase since the beginning of the trading day. The stock's open price was 1.17. Silo Pharma has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Silo Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of June 2024 and ending today, the 31st of August 2024. Click here to learn more.
Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey. Silo Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 2.84 M outstanding shares of which 61.39 K shares are at this time shorted by private and institutional investors with about 0.46 trading days to cover. More on Silo Pharma
Moving against Silo OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Silo OTC Stock Highlights
| President Chairman | Eric Weisblum |
| Thematic Idea | Apparel (View all Themes) |
| Business Concentration | Apparel, Biotechnology, Healthcare, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Silo Pharma [SILO] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Silo Pharma is listed under Apparel category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Silo Pharma's market, we take the total number of its shares issued and multiply it by Silo Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Silo Pharma conducts business under Biotechnology sector and is part of Health Care industry. The entity has 2.84 M outstanding shares of which 61.39 K shares are at this time shorted by private and institutional investors with about 0.46 trading days to cover.
Silo Pharma currently holds about 8.85 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Silo Pharma Probability Of Bankruptcy
Ownership AllocationSilo Pharma has 6.35 % of its outstanding shares held by insiders and 5.6 % owned by institutional holders.
Check Silo Ownership Details
Silo Pharma Risk Profiles
| Risk Adjusted Performance | 0.0335 | |||
| Jensen Alpha | 0.4861 | |||
| Total Risk Alpha | (2.17) | |||
| Sortino Ratio | 0.0423 |
Silo Stock Against Markets
Picking the right benchmark for Silo Pharma otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Silo Pharma otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Silo Pharma is critical whether you are bullish or bearish towards Silo Pharma at a given time. Please also check how Silo Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Silo Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.